Respiratory Syncytial Virus Infection: Enhanced Reactive Oxygen Species Production and Weakened Antioxidant Defenses Worsen Disease Severity.

Authors

Oliviero Sacco, Paola Borgia, Giorgia M Rossi, Angelo Florio, Giovanni A Rossi

Published in

Viruses. Volume 18. Issue 10. Oct 15, 2026. Epub Oct 15, 2026.

Abstract

Respiratory syncytial virus (RSV) is a leading cause of severe respiratory infections in infants and young children globally. The severity of RSV-associated diseases is often ascribed to a dysregulated immune response, characterized by increased secretion of proinflammatory proteins and ineffective T helper type 2 (Th2) cell activity. The host's primary defense against RSV relies on a well-coordinated innate immune response initiated by resident airway epithelial cells, the first target of RSV infection. These cells respond to viral invasion by generating reactive oxygen species (ROS), activating the production of Type I and III interferons, and releasing proinflammatory cytokines and chemokines. Moderate levels of ROS act as key molecules that regulate antiviral signaling, enhancing the host's ability to recognize and eliminate invading pathogens. However, severe RSV infection disrupts cellular homeostasis triggering excessive ROS production, while simultaneously weakening the host's antioxidant defenses. This redox imbalance subverts the activity of key cellular defensive mechanisms, ultimately increasing viral replication, and worsening RSV infection severity. Modulation of oxidative stress may offer an innovative approach in managing the progression and outcome of RSV infection.

PMID:
42944065
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.